Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Gerresheimer AG
  6. Ratings
    GXI   DE000A0LD6E6

GERRESHEIMER AG

(GXI)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Strengths
  • Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
Weaknesses
  • Technically, the stock approaches a strong medium-term resistance at EUR 91.6.
  • The company is in debt and has limited leeway for investment
  • Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart
Sector Other Medical Equipment, Supplies & Distribution
1st jan.Capitalisation (M$)Investor Rating
GERRESHEIMER AG3.36%3 461
ABBOTT LABORATORIES8.49%211 353
MEDTRONIC PLC8.67%170 801
BECTON, DICKINSON AND COMPA..-4.33%69 619
ALIGN TECHNOLOGY, INC.11.97%47 351
HOYA CORPORATION-7.88%44 672
BAXTER INTERNATIONAL INC.7.95%43 557
SARTORIUS STEDIM BIOTECH28.61%41 956
ZIMMER BIOMET HOLDINGS, INC..11.94%36 115
DEXCOM, INC.-2.97%34 692
TERUMO CORPORATION-4.01%28 810
FUJIFILM HOLDINGS CORPORATI..30.29%26 094
AMERISOURCEBERGEN CORPORATI..20.33%24 826
WEST PHARMACEUTICAL SERVICE..17.78%24 319
SYSMEX CORPORATION-10.89%21 276
BIO-RAD LABORATORIES, INC.3.30%18 217
More Results
Financials
Sales 2021 1 474 M 1 793 M 1 793 M
Net income 2021 113 M 137 M 137 M
Net Debt 2021 955 M 1 162 M 1 162 M
P/E ratio 2021 25,3x
Yield 2021 1,48%
Capitalization 2 848 M 3 461 M 3 464 M
EV / Sales 2021 2,58x
EV / Sales 2022 2,39x
Nbr of Employees 9 904
Free-Float 100%
Upcoming event on GERRESHEIMER AG
05/13/21
Surperformance Ratings©
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes